Topics

"Sarepta Therapeutics playing nice with over rejection Duchenne" Drugs and Medication Database

15:25 EST 5th December 2019 | BioPortfolio

Here are the most relevant "Sarepta Therapeutics playing nice with over rejection Duchenne" Drugs and Medications that we have found in our database.

More Information about "Sarepta Therapeutics playing nice with over rejection Duchenne" on BioPortfolio

We have published hundreds of Sarepta Therapeutics playing nice with over rejection Duchenne news stories on BioPortfolio along with dozens of Sarepta Therapeutics playing nice with over rejection Duchenne Clinical Trials and PubMed Articles about Sarepta Therapeutics playing nice with over rejection Duchenne for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sarepta Therapeutics playing nice with over rejection Duchenne Companies in our database. You can also find out about relevant Sarepta Therapeutics playing nice with over rejection Duchenne Drugs and Medications on this site too.

Showing "Sarepta Therapeutics playing nice with over rejection Duchenne" Drugs and Medications 1–25 of 53

Probably Relevant

Kynamro [kastle therapeutics, llc]

NA

Exondys 51 [sarepta therapeutics, inc.]

These highlights do not include all the information needed to use EXONDYS 51® safely and effectively. See full prescribing information for EXONDYS 51.EXONDYS 51 (eteplirsen) injection, for intravenous useInitial U.S. Approval: 2016

Possibly Relevant

Myfortic [novartis pharmaceuticals corporation]

These highlights do not include all the information needed to use MYFORTIC safely and effectively. See full prescribing information for MYFORTIC. MYFORTIC® (mycophenolic acid) delayed-release tablets, for oral use Initial U.S. Approval: 2004

Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Mycophenolic acid [apotex corp]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [major pharmaceuticals]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [american health packaging]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. MYCOPHENOLIC ACID delayed-release tablets,

Mycophenolic acid [golden state medical supply, inc.]

MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED-RELEASE TABLETS. M

Mycophenolic acid [accord healthcare inc.]

These highlights do not include all the information needed to use MYCOPHENOLIC ACID DELAYED RELEASE TABLETS safely and effectively. See full prescribing information for MYCOPHENOLIC ACID DELAYED RELEASE TABLETS. MYCOPHENOLIC ACID delayed release tablets,

Succinylcholine chloride [renaissance lakewood llc]

Succinylcholine Chloride Injection USP, 20 mg/mL

Sirolimus [american health packaging]

These highlights do not include all the information needed to use SIROLIMUS TABLETS safely and effectively. See full prescribing information for SIROLIMUS TABLETS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Sirolimus [greenstone llc]

These highlights do not include all the information needed to use SIROLIMUS safely and effectively. See full prescribing information for SIROLIMUS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999

Oxygen [breathe easy therapeutics, inc]

NA

Thymoglobulin [genzyme corporation]

These highlights do not include all the information needed to use THYMOGLOBULIN safely and effectively. See full prescribing information for THYMOGLOBULIN. THYMOGLOBULIN (anti-thymocyte globulin [rabbit]) for intravenous use Initial U.S. Approval: 1998

Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Sentradine [physician therapeutics llc]

Sentradine

Folotyn [allos therapeutics]

These highlights do not include all the information needed to use FOLOTYN safely and effectively. See full prescribing information for FOLOTYN.FOLOTYN (pralatrexate injection), for intravenous use Initial U.S. Approval: 2009

Urised [key therapeutics]

Urised

Mycophenolate mofetil [zydus pharmaceuticals (usa) inc.]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Mycophenolate mofetil [cadila healthcare limited]

These highlights do not include all the information needed to use Mycophenolate Mofetil for Injection, USP safely and effectively. See full prescribing information for Mycophenolate Mofetil for Injection, USP Initial U.S. Approval: 1995

Simulect [novartis pharmaceuticals corporation]

Simulect (basiliximab) For Injection Rx only Prescribing Information

Mycophenolate mofetil [sandoz inc]

These highlights do not include all the information needed to use MYCOPHENOLATE MOFETIL safely and effectively. See full prescribing information for MYCOPHENOLATE MOFETIL.MYCOPHENOLATE mofetil capsules, for oral useMYCOPHENOLATE mofetil tablets, for oral

Tobramycin [somerset therapeutics, llc]

Rx OnlyFor Topical Ophthalmic Use Only

Mycophenolate mofetil [ascend laboratories, llc]

Mycophenolate Mofetil for Oral Suspension USP



Quick Search